Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants Cannabis Investing News
Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets Life Science Investing
Outlook Therapeutics Provides Business Update and Reports Financial Results for Fiscal Year 2018 Life Science Investing
BELLUS Health Closes $35M Financing to Support Development of its Lead Drug Candidate BLU-5937 for Chronic Cough Pharmaceutical Investing
Medexus Announces New Chief Executive Officer, Chair of the Board of Directors, Other Organizational Updates and Equity Incentive Grants Pharmaceutical Investing
